|
361 |
OF-Pelvis classification of osteoporotic sacral and pelvic ring fractures
Enthalten in BMC musculoskeletal disorders Bd. 22, 29.11.2021, Nr. 1, date:12.2021: 1-10
|
|
|
|
362 |
Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP study
Enthalten in Archives of public health Bd. 81, 25.8.2023, Nr. 1, date:12.2023: 1-6
|
|
|
|
363 |
Osteoporose – Definition, Risikoerfassung, Diagnose, Prävention und Therapie (Update 2024)
Enthalten in Wiener klinische Wochenschrift Bd. 136, 2.10.2024, Nr. 16, date:10.2024: 599-668
|
|
|
|
364 |
Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy
Enthalten in Radiation oncology Bd. 13, 2.3.2018, Nr. 1, date:12.2018: 1-9
|
|
|
|
365 |
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
Enthalten in Radiation oncology Bd. 16, 30.6.2021, Nr. 1, date:12.2021: 1-11
|
|
|
|
366 |
Overground walking patterns after chronic incomplete spinal cord injury show distinct response patterns to unloading
Enthalten in Journal of neuroEngineering and rehabilitation Bd. 15, 12.11.2018, Nr. 1, date:12.2018: 1-12
|
|
|
|
367 |
Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective
Enthalten in Langenbeck's archives of surgery Bd. 408, 10.2.2023, Nr. 1, date:12.2023: 1-15
|
|
|
|
368 |
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
Enthalten in BMC pharmacology & toxicology Bd. 14, 29.8.2013, Nr. 1, date:8.2013: 1-2
|
|
|
|
369 |
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with renal impairment
Enthalten in BMC pharmacology & toxicology Bd. 14, 29.8.2013, Nr. 1, date:8.2013: 1-3
|
|
|
|
370 |
PicoTesla absolute field readings with a hybrid 3He/87Rb magnetometer
Enthalten in The European physical journal / D / Atomic, molecular, optical and plasma physics Bd. 73, 23.7.2019, Nr. 7, date:7.2019: 1-6
|
|
Administration
